These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20571834)
1. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Roder C; Peters V; Kasuya H; Nishizawa T; Takehara Y; Berg D; Schulte C; Khan N; Tatagiba M; Krischek B Acta Neurochir (Wien); 2010 Dec; 152(12):2153-60. PubMed ID: 20571834 [TBL] [Abstract][Full Text] [Related]
2. Analysis of TGFB1 in European and Japanese Moyamoya disease patients. Liu C; Roder C; Schulte C; Kasuya H; Akagawa H; Nishizawa T; Yoneyama T; Okada Y; Khan N; Tatagiba M; Berg D; Krischek B Eur J Med Genet; 2012 Oct; 55(10):531-4. PubMed ID: 22659181 [TBL] [Abstract][Full Text] [Related]
3. Genetic and clinical characteristics of Moyamoya disease in Europeans. Krischek B; Kasuya H; Khan N; Tatagiba M; Roder C; Kraemer M Acta Neurochir Suppl; 2011; 112():31-4. PubMed ID: 21691984 [TBL] [Abstract][Full Text] [Related]
4. Analysis of ACTA2 in European Moyamoya disease patients. Roder C; Peters V; Kasuya H; Nishizawa T; Wakita S; Berg D; Schulte C; Khan N; Tatagiba M; Krischek B Eur J Paediatr Neurol; 2011 Mar; 15(2):117-22. PubMed ID: 20970362 [TBL] [Abstract][Full Text] [Related]
5. Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects. Wang X; Zhang Z; Liu W; Xiong Y; Sun W; Huang X; Jiang Y; Ni G; Sun W; Zhou L; Wu L; Zhu W; Li H; Liu X; Xu G Gene; 2013 Sep; 526(2):437-42. PubMed ID: 23769926 [TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Kang HS; Kim SK; Cho BK; Kim YY; Hwang YS; Wang KC Neurosurgery; 2006 Jun; 58(6):1074-80; discussion 1074-80. PubMed ID: 16723886 [TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008 [TBL] [Abstract][Full Text] [Related]
8. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597 [TBL] [Abstract][Full Text] [Related]
9. Common genetic polymorphisms in moyamoya and atherosclerotic disease in Europeans. Roder C; Peters V; Kasuya H; Nishizawa T; Takehara Y; Berg D; Schulte C; Khan N; Tatagiba M; Krischek B Childs Nerv Syst; 2011 Feb; 27(2):245-52. PubMed ID: 20694560 [TBL] [Abstract][Full Text] [Related]
10. Lack of association between the TGF-beta1 gene polymorphisms and recurrent spontaneous abortion. Amani D; Dehaghani AS; Zolghadri J; Ravangard F; Niikawa N; Yoshiura K; Ghaderi A J Reprod Immunol; 2005 Dec; 68(1-2):91-103. PubMed ID: 16236363 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression. Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms. van der Paardt M; Crusius JB; García-González MA; Dijkmans BA; Peña AS; van der Horst-Bruinsma IE Ann Rheum Dis; 2005 Apr; 64(4):616-9. PubMed ID: 15769917 [TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection. Hussein A; Askar E; Elsaeid M; Schaefer F Nephrol Dial Transplant; 2010 Mar; 25(3):779-85. PubMed ID: 19861314 [TBL] [Abstract][Full Text] [Related]
14. Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia. Lee YG; Kim I; Kim JH; Bae JY; Kwon JH; Shin DY; Lee JE; Song EY; Kim HK; Yoon SS; Park SS; Lee DS; Han KS; Park MH; Hong YC; Park S; Kim BK Ann Hematol; 2011 May; 90(5):515-21. PubMed ID: 20953611 [TBL] [Abstract][Full Text] [Related]
15. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955 [TBL] [Abstract][Full Text] [Related]
16. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility. Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms located in TGFB1, AGTR1, and VEGFA genes are associated to chronic renal allograft dysfunction. Jiménez-Sousa MA; Fernández-Rodríguez A; Heredia M; Tamayo E; Guzmán-Fulgencio M; Lajo C; López E; Gómez-Herreras JI; Bustamante J; Bermejo-Martín JF; Resino S Cytokine; 2012 Jun; 58(3):321-6. PubMed ID: 22433249 [TBL] [Abstract][Full Text] [Related]
18. Lack of association between COPD and transforming growth factor-beta1 (TGFB1) genetic polymorphisms in Koreans. Yoon HI; Silverman EK; Lee HW; Yoo CG; Lee CT; Chung HS; Kim YW; Han SK; Shim YS; Yim JJ Int J Tuberc Lung Dis; 2006 May; 10(5):504-9. PubMed ID: 16704031 [TBL] [Abstract][Full Text] [Related]